Compare ARK Genomic Revolution ETF (ARKG) vs FTAI Aviation Ltd (FTAI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs FTAI Aviation Ltd — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while FTAI Aviation Ltd trades at $224.9 (market cap $23.33B). The key difference: FTAI Aviation Ltd pays a 0.66% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, FTAI Aviation Ltd nearer its low. Which is the better fit depends on your goals.
| ARKG | FTAI | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $43.57 | $310.04 |
52-Week Low | $23.09 | $109.92 |
Market Cap | — | $23.33B |
Enterprise Value | — | $26.37B |
Dividend Yield | — | 0.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
FTAI Aviation trades at $227.35, down 0.29% on the day, with a bearish technical signal despite strong analyst consensus. The company reported Q1 2026 EPS of $1.29, missing expectations of $1.50, but maintains robust revenue growth and a net income margin of 18.92%. Recent strategic collaborations and a dividend increase to $0.45 highlight management's confidence in long-term prospects, particularly in aerospace services and data center power solutions.
Outlook remains positive driven by aerospace demand and innovation in power solutions, though risks include earnings misses and high valuation multiples. With 100% buy ratings from analysts and institutional support, the stock offers growth potential but requires monitoring of execution against forecasts and competitive pressures in evolving markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About FTAI Aviation Ltd
FTAI Aviation owns and maintains a fleet of commercial aircraft and engines. It focuses on the specialized maintenance of the CFM56 engine, helping airlines reduce costs through efficient asset management.
Read more on FTAI →
